Invention for Innovation Dementia Stage 1 Minutes
- Published: 25 April 2022
- Version: V1 - April 2022
- 1 min read
Minutes of the Invention for Innovation (i4i) Programme Sub-Committee Meeting to discuss applications to Dementia Stage 1
Date and Location
Meeting held on on Thursday 3rd February 2022 via Zoom Virtual Meeting
In attendance
Prof David Llewellyn (Chair)
Professor Blossom Stephan (Deputy Chair)
i4i Secretariat
Professor Mike Lewis (Programme Director)
Dr Ruth Nebauer (Assistant Director)
Dr Andrew Barber
Ami Hodges
Mrs Paula Milton
Mr Edwin Tucker
Dr Xi Ye
Observers
Dr Anni Bailey (DHSC)
Caroline de Winter (NIHR Operations)
The following Stage 1 applications were discussed by the Sub-Committee and invited to progress to Stage 2
NIHR204279: Diagnosing dementia using Fastball neurocognitive assessment
Outcome: Invited to Stage 2
NIHR204280: Digital assessment of auditory perception in dementia (DIADEM)
Outcome: Invited to Stage 2
NIHR204283: Spatial biomarkers of early Alzheimer's disease (SABRE)
Outcome: Invited to Stage 2
NIHR204284: Clinical validation and commercialisation of the ReaCTIVE app: A proactive, interactive cognitive monitoring and intervention solution for people with early cognitive impairment
Outcome: Invited to Stage 2
NIHR204286: Detecting and monitoring dementia using dynamic digital biomarkers of night-time behaviour
Outcome: Invited to Stage 2
NIHR204289: Remote monitoring and early diagnosis in patients with Mild Cognitive Impairment in the community (ReMCI)
Outcome: Invited to Stage 2
NIHR204290: Identifying older patients at high short-term risk of dementia and cognitive decline using routinely collected hospital electronic clinical and brain imaging data to improve care
Outcome: Invited to Stage 2
Stage 1 applications not invited to submit to Stage 2:
NIHR204277: Development of a digital device application for future dementia risk estimation: A validation study
Outcome: Reject
NIHR204278: AI-derived Parkinson's Disease Dementia stratification tool to identify at-risk individuals for monitoring, personalised care plans and focused drug clinical trials
Outcome: Reject
NIHR204281: STRATification of people with cognitive Impairment using EEG (STRATEEG)
Outcome: Reject
NIHR204282: Pupil light response and saccadic eye movement in dementia
Outcome: Reject
NIHR204285: An Eye for Dementia
Outcome: Reject
NIHR204287: Developing and validating a GP-led infrastructure for digitally-based early dementia diagnosis
Outcome: Reject
NIHR204288: Gait evalUation as an Indicator of DEmentia subtypes study (GUIDE)
Outcome: Reject